Cargando…

Safety of human papillomavirus vaccines in healthy young women: a meta-analysis of 24 controlled studies

BACKGROUND: Human papillomavirus (HPV) vaccines have been shown to be effective for the eradication of HPV and prevention of cervical cancer. However, the number of women who receive HPV vaccinations has decreased over the last several years in Japan, due to concerns about adverse reactions associat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ogawa, Yukari, Takei, Hinako, Ogawa, Ryuichi, Mihara, Kiyoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5504559/ https://www.ncbi.nlm.nih.gov/pubmed/28702209 http://dx.doi.org/10.1186/s40780-017-0087-6

Ejemplares similares

A meta-analysis of observational studies on anticholinergic burden and fracture risk: evaluation of conventional burden scales
por: Ogawa, Yukari, et al.
Publicado: (2021)

Incidence and Types of Human Papillomavirus Infections in Adolescent Girls and Young Women Immunized With the Human Papillomavirus Vaccine
por: Schlecht, Nicolas F., et al.
Publicado: (2021)

Anticholinergic and Sedative Drug Burden and Functional Recovery after Cerebrovascular Accident: A Retrospective Descriptive Study
por: Ogawa, Yukari, et al.
Publicado: (2020)

Efficacy, immunogenicity, and safety of a 9-valent human papillomavirus vaccine in Latin American girls, boys, and young women()
por: Ruiz-Sternberg, Ángela María, et al.
Publicado: (2017)

Human papillomavirus vaccination for young survivors of cancer
por: Brewer, Noel T, et al.
Publicado: (2022)

Human papillomavirus and vaccination: knowledge, attitudes, and behavioural intention in adolescents and young women in Italy
por: Di Giuseppe, G, et al.
Publicado: (2008)

Ethnic Variations in Perception of Human Papillomavirus and its Vaccination among Young Women in Nepal .
por: Sathian, Brijesh, et al.
Publicado: (2017)

1242. Safety and Immunogenicity of Novel 24-Valent Pneumococcal Vaccine in Healthy Adults
por: Chichili, Gurunadh, et al.
Publicado: (2020)

Human papillomavirus vaccine effectiveness by age at first vaccination among Japanese women
por: Onuki, Mamiko, et al.
Publicado: (2022)

Safety of human papillomavirus vaccines: a review
por: Stillo, Michela, et al.
Publicado: (2015)

Discrepancies in the evaluation of the safety of the human papillomavirus vaccine
por: Cervantes, Jorge L, et al.
Publicado: (2018)

Human papillomavirus 16/18 AS04-adjuvanted cervical cancer vaccine: immunogenicity and safety in 15-25 years old healthy Korean women
por: Kim, Seung Cheol, et al.
Publicado: (2011)

Safety of Human Papillomavirus 9-Valent Vaccine: A Meta-Analysis of Randomized Trials
por: Costa, Ana Paula Ferreira, et al.
Publicado: (2017)

An appraisal of theoretical approaches to examining behaviours in relation to Human Papillomavirus (HPV) vaccination of young women
por: Batista Ferrer, Harriet, et al.
Publicado: (2015)

Safety and Efficacy Data on Vaccines and Immunization to Human Papillomavirus
por: Kash, Natalie, et al.
Publicado: (2015)

Long-term efficacy and safety of human papillomavirus vaccination
por: De Vincenzo, Rosa, et al.
Publicado: (2014)

Comment on “Safety of Human Papillomavirus Vaccines: An Updated Review”
por: Chandler, Rebecca Ellen, et al.
Publicado: (2018)

Drivers and barriers to acceptance of human-papillomavirus vaccination among young women: a qualitative and quantitative study
por: Mortensen, Gitte Lee
Publicado: (2010)

Effects of nighttime lavender aromatherapy on mood and physiological indices of stress in healthy young females
por: Sazawa, Kanako, et al.
Publicado: (2022)

Human papillomavirus seroprevalence and seroconversion following baseline detection of nine human papillomavirus types in young women
por: Brown, Darron R., et al.
Publicado: (2022)

Azuki Bean Juice Lowers Serum Triglyceride Concentrations in Healthy Young Women
por: Maruyama, Chizuko, et al.
Publicado: (2008)

Early effect of bivalent human papillomavirus vaccination on cytology outcomes in cervical samples among young women in the Netherlands
por: Schurink‐van ’t Klooster, Tessa M., et al.
Publicado: (2023)

Efficacy and safety of human papillomavirus vaccination in HIV-infected patients: a systematic review and meta-analysis
por: Zizza, Antonella, et al.
Publicado: (2021)

Different dose series of human papillomavirus vaccine in young females: a pair-wise meta-analysis and network meta-analysis from randomized controlled trials
por: Kemin, Li, et al.
Publicado: (2023)

Bacterial vaginosis and cervical human papillomavirus infection in young and adult women: a systematic review and meta-analysis
por: Martins, Bruno César Teodoro, et al.
Publicado: (2022)

Vaginal microbiota and human papillomavirus infection among young Swedish women
por: Cheng, Liqin, et al.
Publicado: (2020)

Investigation of safety and efficacy of the new more thermostable formulation of Flolan (epoprostenol) in Japanese patients with pulmonary arterial hypertension (PAH)—An open-label, single-arm study
por: Mihara, Kazuko, et al.
Publicado: (2018)

Uptake of Human Papillomavirus Vaccine and Intention to Vaccinate among Healthy Pregnant Women in Serbia: A Cross-Sectional Study on Awareness, Knowledge, and Attitudes
por: Markovic-Denic, Ljiljana, et al.
Publicado: (2021)

Prevalence of human papillomavirus in young Italian women with normal cytology: how should we adapt the national vaccination policy?
por: Panatto, Donatella, et al.
Publicado: (2013)

Attitudes, Knowledge and Factors Associated with Human Papillomavirus (HPV) Vaccine Uptake in Adolescent Girls and Young Women in Victoria, Australia
por: Tung, Iris L. Y., et al.
Publicado: (2016)

High human papillomavirus (HPV) prevalence in South African adolescents and young women encourages expanded HPV vaccination campaigns
por: Mbulawa, Zizipho Z. A., et al.
Publicado: (2018)

The association between viral load and concurrent human papillomavirus infection at the genital and anal sites of young women and the impact of vaccination
por: van Eer, Kahren, et al.
Publicado: (2021)

Human papillomavirus prevalence and vaccine effectiveness in young women in Germany, 2017/2018: results from a nationwide study
por: Loenenbach, Anna, et al.
Publicado: (2023)

Safety and Immunogenicity Profile of Human Papillomavirus-16/18 AS04 Adjuvant Cervical Cancer Vaccine: A Randomized Controlled Trial in Healthy Adolescent Girls of Bangladesh
por: Khatun, Sabera, et al.
Publicado: (2012)

High-risk human papillomavirus cervical infections among healthy women in Guadeloupe()
por: Cordel, Nadège, et al.
Publicado: (2015)

Safety and Immunogenicity of Human Papillomavirus-16/18 AS04-Adjuvanted Vaccine: A Randomized Trial in 10–25-Year-Old HIV-Seronegative African Girls and Young Women
por: Sow, Papa Salif, et al.
Publicado: (2013)

Safety and immunogenicity of human papillomavirus vaccination in juvenile patients with rheumatic diseases
por: Heijstek, MW, et al.
Publicado: (2011)

A Broad Safety Assessment of the 9-Valent Human Papillomavirus Vaccine
por: Yih, W Katherine, et al.
Publicado: (2021)

Extended surveillance to assess safety of 9-valent human papillomavirus vaccine
por: Sundaram, Maria E., et al.
Publicado: (2022)

Immunogenicity, efficacy, and safety of human papillomavirus vaccine: Data from China
por: Li, Mingzhu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vojr27ig11fc70q4lbb90e8ir6